SACUBITRIL/VALSARTAN-DR.REDDY'S (Dr Reddys Laboratories Australia Pty Ltd)
Product name
SACUBITRIL/VALSARTAN-DR.REDDY'S
Date registered
Evaluation commenced
Decision date
Approval time
183 (255 working days)
Active ingredients
sacubitril, valsartan
Registration type
New generic medicine
Indication
[TRADE NAME] is indicated in adult patients for the treatment of chronic heart failure (NYHA Class II-IV) with reduced ejection fraction.